The purpose of the study was to investigate the mechanism of total flavone of Desmodium styracifolium (TFDS) in regulating the formation of urinary calculi. Protein levels of KIM-1, LC3-II, p-p38 were measured by Western blot. The effect of different COM concentrations, different TFDS concentrations, SB203580 (specific inhibitor of p38/MAPK), and overexpression of KIM-1 on cell viability were detected by WST-1 assay. The apoptotic cells and FITC positive cells were detected by flow cytometry. HK-2 cell viability decreased with the increase of COM concentration, and the protein levels of KIM-1, LC3-II, and p-p38 increased with the time. Blocking the p38/MAPK pathway or co-cultured with TFDS inhibited the effects of COM on apoptosis and autophagy of HK-2 cells. In addition, blocking the p38/MAPK pathway inhibited the expression of KIM-1. In COM-induced cells, after treated with SB203580, overexpression of KIM-1 could reverse the protection effect of SB203580 on COM-induced cell damage and the inhibition of SB203580 on COM-induced excessive autophagy, suggesting p38/MAPK regulated KIM-1 to regulate COM-induced cell apoptosis and autophagy. Finally, we proved that TFDS inhibited p38/MAPK pathway. And the protection effect of COM-induced cell injury increased with the increase of TFDS concentration, and the adhesion between COM and cells decreased with the increase of TFDS concentration. With the increase of the concentration of TFDS, p38/MAPK pathway was gradually inhibited, and KIM-1 and autophagy related proteins were decreased. TFDS inhibited HK-2 cell apoptosis and autophagy by regulating KIM-1 via p38/MAPK pathway.
Total flavone of Desmodium styracifoliumKIM-1 LC3-II p38/MAPK
This is a preview of subscription content, log in to check access.
This project was supported by research grants awarded by the Traditional Chinese medicine and Western Medicine Research of Tianjin health and Family Planning Commission (2015134).
Compliance with ethical standards
Conflict of interest
The authors have no actual or potential conflict of interest to declare.
Chung SD, Liu SP, Lin HC (2013) A population-based study on the association between urinary calculi and kidney cancer. CUAJ-Can Urol Assoc 7:E716–E721. doi:10.5489/cuaj.366CrossRefGoogle Scholar
Gan QZ, Sun XY, Bhadja P, Yao XQ, Ouyang JM (2016) Reinjury risk of nano-calcium oxalate monohydrate and calcium oxalate dihydrate crystals on injured renal epithelial cells: aggravation of crystal adhesion and aggregation. Int J Nanomed 11:2839–2854. doi:10.2147/IJN.S104505Google Scholar
Mittal A, Tandon S, Singla SK, Tandon C (2016) In vitro inhibition of calcium oxalate crystallization and crystal adherence to renal tubular epithelial cells by Terminalia arjuna. Urolithiasis 44:287CrossRefPubMedGoogle Scholar
Liu L, Chen M, Chen X (2015) Analysis of alcohol dehydrogenase inhibitors from Desmodium styracifolium using centrifugal ultrafiltration coupled with HPLC-MS. J Serb Chem Soc 80:23CrossRefGoogle Scholar
Wagner H, Bauer R, Melchart D, Xiao P-G, Staudinger A (2015) Herba Lysimachiae christiniae–Jinqiancao. Springer International Publishing, ChamCrossRefGoogle Scholar
Xiang S, Zhou J, Li J, Wang Q, Zhang Q, Zhao Z, Zhang L, Chen Z, Wang S (2015) Antilithic effects of extracts from different polarity fractions of Desmodium styracifolium on experimentally induced urolithiasis in rats. Urolithiasis 43:433–439CrossRefPubMedGoogle Scholar
Edvardsson VO, Indridason OS, Haraldsson G, Kjartansson O, Palsson R (2013) Temporal trends in the incidence of kidney stone disease. Kidney Int 83:146CrossRefPubMedGoogle Scholar
Ferraro PM, Curhan GC, D’Addessi A, Gambaro G (2016) Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. J Nephrol 30:1–7Google Scholar
Chongruksut W, Lojanapiwat B, Tawichasri C, Paichitvichean S, Euathrongchit J, Ayudhya VC, Patumanond J (2012) Predictors for kidney stones recurrence following extracorporeal shock wave lithotripsy (ESWL) or percutaneous nephrolithotomy (PCNL). J Med Assoc Thai 95:342–348PubMedGoogle Scholar
Ouyang JM, Yao XQ, Tan J, Wang FX (2011) Renal epithelial cell injury and its promoting role in formation of calcium oxalate monohydrate. J Biol Inorg Chem 16:405–416CrossRefPubMedGoogle Scholar
Mi J, Duan J, Zhang J, Lu J, Wang H, Wang Z (2012) Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats. Urolithiasis 40:151–161Google Scholar
Rodgers AL, Webber D, Ramsout R, Gohel MD (2014) Herbal preparations affect the kinetic factors of calcium oxalate crystallization in synthetic urine: implications for kidney stone therapy. Urolithiasis 42:221–225CrossRefPubMedGoogle Scholar
Zhao M, Duan JA, Che CT (2007) Isoflavanones and their O -glycosides from Desmodium styracifolium. Phytochemistry 68:1471–1479CrossRefPubMedGoogle Scholar
Zhou C, Luo JG, Kong LY (2012) Quality evaluation of Desmodium styracifolium using high-performance liquid chromatography with photodiode array detection and electrospray ionisation tandem mass spectrometry. Phytochem Analysis 23:240–247CrossRefGoogle Scholar